Cooper Research and Development Expenses 2010-2024 | COO

Cooper annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Cooper research and development expenses for the quarter ending July 31, 2024 were $0.039B, a 6.85% increase year-over-year.
  • Cooper research and development expenses for the twelve months ending July 31, 2024 were $0.154B, a 18.72% increase year-over-year.
  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
  • Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.
  • Cooper annual research and development expenses for 2021 were $0.093B, a 0.64% decline from 2020.
Cooper Annual Research and Development Expenses
(Millions of US $)
2023 $137
2022 $110
2021 $93
2020 $93
2019 $87
2018 $85
2017 $69
2016 $65
2015 $70
2014 $66
2013 $59
2012 $52
2011 $44
2010 $35
2009 $33
Cooper Quarterly Research and Development Expenses
(Millions of US $)
2024-07-31 $39
2024-04-30 $39
2024-01-31 $40
2023-10-31 $37
2023-07-31 $37
2023-04-30 $33
2023-01-31 $32
2022-10-31 $29
2022-07-31 $29
2022-04-30 $26
2022-01-31 $26
2021-10-31 $26
2021-07-31 $25
2021-04-30 $21
2021-01-31 $21
2020-10-31 $26
2020-07-31 $22
2020-04-30 $24
2020-01-31 $22
2019-10-31 $23
2019-07-31 $22
2019-04-30 $21
2019-01-31 $21
2018-10-31 $23
2018-07-31 $23
2018-04-30 $21
2018-01-31 $19
2017-10-31 $19
2017-07-31 $18
2017-04-30 $17
2017-01-31 $16
2016-10-31 $18
2016-07-31 $16
2016-04-30 $17
2016-01-31 $15
2015-10-31 $18
2015-07-31 $18
2015-04-30 $17
2015-01-31 $16
2014-10-31 $18
2014-07-31 $16
2014-04-30 $16
2014-01-31 $16
2013-10-31 $16
2013-07-31 $15
2013-04-30 $14
2013-01-31 $14
2012-10-31 $14
2012-07-31 $13
2012-04-30 $13
2012-01-31 $11
2011-10-31 $12
2011-07-31 $12
2011-04-30 $10
2011-01-31 $10
2010-10-31 $10
2010-07-31 $9
2010-04-30 $9
2010-01-31 $8
2009-10-31 $8
2009-07-31 $8
2009-04-30 $10
2009-01-31 $7
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.662B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71